Jingwen Ai

机构：Fudan University, Huashan Hospital · ORCID：0000-0002-5152-1557

发表论文 157 篇 · 总被引 5181 次 · h-index 38

代表论文

• Integrated multi-omics characterization across clinically relevant subgroups of long COVID (2024 · National Science Review · 被引 16)
• Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomized, double-blind, placebo-controlled phase 2/3 trial (2024 · Clinical Microbiology and Infection · 被引 16)
• Pertussis clinical profile shift, severity, prediction in a tertiary hospital: A comparative study before, during, and after COVID-19 in Southern China (2024 · Journal of Infection and Public Health · 被引 15)
• Multi-omics landscapes reveal heterogeneity in long COVID patients characterized with enhanced neutrophil activity (2024 · Journal of Translational Medicine · 被引 15)
• Global resurgence of Chikungunya virus: outbreak drivers and emerging solutions (2025 · Emerging Microbes & Infections · 被引 11)
• Safety, tolerability, and pharmacokinetics of a novel anti-influenza agent ZX-7101A tablets in healthy chinese participants: A first-in-human phase I clinical study (2024 · International Journal of Antimicrobial Agents · 被引 7)